ResearcherVirginia Mason Medical CenterActive in the last 2 years
Richard A. Kozarek
Matched on ORCID iD 0000-0002-9745-7538; OpenAlex author ID A5063647285. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 12
- The Palliation of Unresectable Pancreatic Cancer: Evolution from Surgery to Minimally Invasive Modalities. Last author DOI 10.3390/jcm14144997↗
- Bidirectional relationship between acute pancreatitis and pancreatic cancer. Co-author DOI 10.1097/mog.0000000000001051↗
- Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland. Co-author DOI 10.1002/jso.25498↗
- Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. Last author DOI 10.1016/j.gie.2019.06.032↗
- Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma? Co-author DOI 10.1016/j.hpb.2018.03.014↗
- Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival? Co-author DOI 10.1245/s10434-018-6334-8↗
- Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience. Co-author DOI 10.1016/j.amjsurg.2016.04.008↗
- Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective. Last author DOI 10.1245/s10434-016-5716-z↗
- What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer? Last author DOI 10.4253/wjge.v8.i7.319↗
- Survival and clinical outcome after endoscopic duodenal stent placement for malignant gastric outlet obstruction: comparison of pancreatic cancer and nonpancre… Last author DOI 10.1016/j.gie.2015.01.026↗
- Role of preoperative palliation of jaundice in pancreatic cancer. Co-author DOI 10.1007/s00534-013-0612-4↗
- Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience. Last author DOI 10.1016/j.gie.2011.04.029↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Adnan A. Alseidi · 5 shared papers, 2017–2019 · strength 0.38
- Paper Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of… DOI 10.1002/jso.25498↗
- Paper Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenoca… DOI 10.1016/j.hpb.2018.03.014↗
- Paper Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improve… DOI 10.1245/s10434-018-6334-8↗
- Flavio G. Rocha · 5 shared papers, 2017–2019 · strength 0.38
- Paper Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of… DOI 10.1002/jso.25498↗
- Paper Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenoca… DOI 10.1016/j.hpb.2018.03.014↗
- Paper Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improve… DOI 10.1245/s10434-018-6334-8↗
- Stephen Y. Oh · 5 shared papers, 2015–2018 · strength 0.35
- Paper What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer? DOI 10.4253/wjge.v8.i7.319↗
- Paper Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenoca… DOI 10.1016/j.hpb.2018.03.014↗
- Paper Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-i… DOI 10.1016/j.amjsurg.2016.04.008↗
- Vincent J. Picozzi · 6 shared papers, 2011–2018 · strength 0.35
- Paper Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenoca… DOI 10.1016/j.hpb.2018.03.014↗
- Paper Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improve… DOI 10.1245/s10434-018-6334-8↗
- Paper Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-i… DOI 10.1016/j.amjsurg.2016.04.008↗
- Lauren M. Wancata · 1 shared paper, 2025 · strength 0.30
- Muaaz Masood · 1 shared paper, 2025 · strength 0.30
- Anna Evans Phillips · 1 shared paper, 2024 · strength 0.28
- Murray Korc · 1 shared paper, 2024 · strength 0.28
- Christie Y. Jeon · 1 shared paper, 2024 · strength 0.28
- Scott W. Helton · 3 shared papers, 2015–2019 · strength 0.21
- Paper Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of… DOI 10.1002/jso.25498↗
- Paper Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-i… DOI 10.1016/j.amjsurg.2016.04.008↗
- Paper Survival and clinical outcome after endoscopic duodenal stent placement for malignant gastric outlet obstruction: compa… DOI 10.1016/j.gie.2015.01.026↗
- William Scott Helton · 3 shared papers, 2017–2018 · strength 0.21
- Paper Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenoca… DOI 10.1016/j.hpb.2018.03.014↗
- Paper Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improve… DOI 10.1245/s10434-018-6334-8↗
- Paper Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Mu… DOI 10.1245/s10434-016-5716-z↗
- John Bart Rose · 1 shared paper, 2019 · strength 0.10
- Jong Jin Hyun · 1 shared paper, 2019 · strength 0.10
- L. William Traverso · 2 shared papers, 2011–2017 · strength 0.09
- Paper Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Mu… DOI 10.1245/s10434-016-5716-z↗
- Paper Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-y… DOI 10.1016/j.gie.2011.04.029↗
- Hiroyuki Isayama · 1 shared paper, 2019 · strength 0.09
- Stuart Sherman · 1 shared paper, 2019 · strength 0.09
- Guido Costamagna · 1 shared paper, 2019 · strength 0.09
- Jacques M.E. Deviere · 1 shared paper, 2019 · strength 0.09
- Dong Wan Seo · 1 shared paper, 2019 · strength 0.09
- Yousuke Nakai · 1 shared paper, 2019 · strength 0.09
- Kulwinder S. Dua · 1 shared paper, 2019 · strength 0.09
- Zaheer S. Kanji · 1 shared paper, 2018 · strength 0.07
- Jesse Clanton · 1 shared paper, 2018 · strength 0.07
- Rahul Pannala · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.